Moreover, Zhou and coauthors revealed that RRM2 overexpression was closely related to poor prognosis of HCC patients, and RRM2 was enriched in the p53 signaling pathway (Zhou et al., 2019b). Here, TP53 is linked to hepatocellular carcinoma.